Hepatocellular Carcinoma Patients as an Ideal Study Population for Immune Checkpoint Inhibitors in Hepatitis B. Xiao G, Ren H. J Hepatol 2024 Oct 16:S0168-8278(24)02630-8. doi: 10.1016/j.jhep.2024.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Xiao G, Ren H. Hepatocellular Carcinoma Patients as an Ideal Study Population for Immune Checkpoint Inhibitors in Hepatitis B. J Hepatol 2024 Oct 16:S0168-8278(24)02630-8. doi: 10.1016/j.jhep.2024.
PMID: 39423866